The antiinfective medicine sales in Germany are projected to increase steadily from 2024 to 2028. The value per capita in US Dollars PPP shows an incremental growth from 45.6 to 49.2. Based on the 2023 baseline for year-on-year variations, the growth rates for the years 2024, 2025, 2026, 2027, and 2028 are as follows: 1.97%, 1.98%, 1.94%, and 1.86% respectively. The Compound Annual Growth Rate (CAGR) over the five-year period stands at approximately 1.94%.
Future trends to watch for include advancements in antimicrobial resistance strategies, the emergence of new drug classes, and the impact of regulatory changes on the antiinfective market. Monitoring these trends will provide insights into the evolving landscape and potential growth opportunities in the sector.
